A new partnership enterprise, Tianjin Xinxian Yuan Enterprise Management Partnership (Limited Partnership), has been established in Tianjin with a registered capital of 4.606 billion RMB. The enterprise is a joint venture involving Xinda Investment Co., Ltd., China Cinda, and Henan Deyu Industrial Co., Ltd., and its business scope includes enterprise management. Separately, Yiling Pharmaceutical announced that its subsidiary, Wanyang Hengshui Pharmaceutical Co., Ltd., received approval from the National Medical Products Administration for its Irbesartan chemical raw material drug application. AI
RANK_REASON Significant funding/establishment of a new enterprise with substantial capital. [lever_c_demoted from significant: ic=1 ai=0.1]
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →
